Corvus Pharmaceuticals In... (CRVS)

CRVS trades at $5.42, 35.5% above the near-term max pain of $4 expiring Sep 19, 2025 (34 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($1-$4), reflecting growing call interest at higher strikes. Key magnetic zone at 4 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for CRVS shows an upward trend from 1 to 4, suggesting bullish positioning in longer-dated options. The 92% spread signals divergent expectations across timeframes. Most levels below 5.42 may cap rallies. Strong magnetic level at 4 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.